1. IDDF2019-ABS-0131 Algorithms using noninvasive tests can accurately identify patients with advanced fibrosis due to NASH: data from the STELLAR clinical trials. (June 2019) Authors: Wong, Vincent Wai-Sun; Younossi, Zobair; Lawitz, Eric; Alkhouri, Naim; Romero-Gomez, Manuel; Okanoue, Takeshi; Trauner, Michael; Kersey, Kathryn; Li, Georgia; Subramanian, Mani; Myers, Robert; Djedjos, Stephen; Han, Ling; Chen, Guang; Nguyen, Tuan; Kohli, Anita; Bzowej, Natalie; Younes, Ziad; Sar... Journal: Gut Issue: Volume 68(2019)Supplement 1 Page Start: A135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. IDDF2019-ABS-0133 Routinely available noninvasive tests discriminate advanced fibrosis due to NASH in the phase 3 STELLAR trials of the ASK1 inhibitor selonsertib. (June 2019) Authors: Wong, Vincent Wai-Sun; Anstee, Quentin; Lawitz, Eric; Alkhouri, Naim; Romero-Gomez, Manuel; Okanoue, Takeshi; Trauner, Michael; Kersey, Kathryn; Li, Georgia; Subramanian, Mani; Myers, Robert; Djedjos, Stephen; Han, Ling; Nguyen, Tuan; Kohli, Anita; Bzowej, Natalie; Younes, Ziad; Sarin, Shiv; Shif... Journal: Gut Issue: Volume 68(2019)Supplement 1 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Liver Transplantation Using Hepatitis C Virus–Viremic Donors Into Hepatitis C Virus–Aviremic Recipients as Standard of Care. Issue 4 (20th April 2021) Authors: Bohorquez, Humberto; Bugeaud, Emily; Bzowej, Natalie; Scheuermann, Jennifer; Hand, Jonathan; Bruce, David; Carmody, Ian; Cohen, Ari; Joshi, Shobha; Seal, John; Sonnier, Dennis; Therapondos, George; Girgrah, Nigel; Anders, Stephanie; Loss, George E. Journal: Liver transplantation Issue: Volume 27:Issue 4(2021) Page Start: 548 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Noninvasive Tests Accurately Identify Advanced Fibrosis due to NASH: Baseline Data From the STELLAR Trials. Issue 5 (19th August 2019) Authors: Anstee, Quentin M.; Lawitz, Eric J.; Alkhouri, Naim; Wong, Vincent Wai‐Sun; Romero‐Gomez, Manuel; Okanoue, Takeshi; Trauner, Michael; Kersey, Kathryn; Li, Georgia; Han, Ling; Jia, Catherine; Wang, Lulu; Chen, Guang; Subramanian, G. Mani; Myers, Robert P.; Djedjos, C. Stephen; Kohli, Anita; Bzowej... Journal: Hepatology Issue: Volume 70:Issue 5(2019) Page Start: 1521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PROPEL: A randomized trial of mericitabine plus peginterferon alpha‐2a/ribavirin therapy in treatment‐naïve HCV genotype 1/4 patients. Issue 2 (26th June 2013) Authors: Wedemeyer, Heiner; Jensen, Donald; Herring, Robert; Ferenci, Peter; Ma, Mang‐Ming; Zeuzem, Stefan; Rodriguez‐Torres, Maribel; Bzowej, Natalie; Pockros, Paul; Vierling, John; Ipe, David; Munson, Marie Lou; Chen, Ya‐Chi; Najera, Isabel; Thommes, James Journal: Hepatology Issue: Volume 58:Issue 2(2013:Aug.) Page Start: 524 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation. Issue 6 (9th April 2013) Authors: Teperman, Lewis W.; Poordad, Fred; Bzowej, Natalie; Martin, Paul; Pungpapong, Surakit; Schiano, Thomas; Flaherty, John; Dinh, Phillip; Rossi, Stephen; Subramanian, G. Mani; Spivey, James Journal: Liver transplantation Issue: Volume 19:Issue 6(2013:Jun.) Page Start: 594 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗